J. Dhainaut

发表

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

M. Levy, J. Marshall, J. Vincent, 2007, Intensive Care Medicine.

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

M. Levy, J. Marshall, J. Vincent, 2007, Intensive Care Medicine.

CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group.

J. Dhainaut, S. Stephens, J. Vincent, 1995, Critical care medicine.

Investigational Therapy of Sepsis: Anti-TNF, IL-1ra, Anti-PAF and G-CSF

J. Dhainaut, J. Mira, F. Brunet, 1995 .

Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trial.

S. Opal, R. Wunderink, C. Doig, 2011, American journal of respiratory and critical care medicine.

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

Richard Beale, Mitchell M. Levy, Margaret M. Parker, 2008 .

Mechanisms of decreased left ventricular preload during continuous positive pressure ventilation in ARDS.

J. Dhainaut, F. Brunet, J. Devaux, 1986, Chest.

Depression influences the comprehension of patients in the emergency department

C. Elie, J. Dhainaut, D. Pateron, 2009 .

Regulation of myocardial oxygen delivery

J. Dhainaut, B. Schremmer, 2005, Intensive Care Medicine.

Coronary Hemodynamics and Myocardial Metabolism in Sepsis and Septic Shock

J. Dhainaut, J. Mira, J. Dall'ava, 1993 .

The Coronary Circulation and the Myocardial Oxygen Supply/Uptake Relationship: A Short Review

J. Dhainaut, B. Schremmer, Lanore Jj, 1991 .

Accuracy assessment for three fiberoptic pulmonary artery catheters for SvO2 monitoring.

A. Armaganidis, J. Dhainaut, J. Mira, 1994, Intensive care medicine.

Accuracy assessment for three fiberoptic pulmonary artery catheters for $$S\bar vO_2 $$ monitoring

A. Armaganidis, J. Dhainaut, J. Mira, 1994, Intensive Care Medicine.

Sevrage de la ventilation artificielle: intérêt du monitorage continu de la So2

A. Armaganidis, J. Dhainaut, 1989 .

Heart Failure in Septic Shock

J. Dhainaut, Y. Tulzo, F. Brunet, 1988 .

Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock.

J. Dhainaut, F. Brunet, J. Dall'ava-Santucci, 1987, Circulation.

THE SAFETY OF DROTRECOGIN ALFA (ACTIVATED): INDEPTH DATA ANALYSIS SUGGESTS SURVIVAL BENEFIT INDEPENDENT OF SERIOUS ADVERSE EVENT OCCURRENCES

S. Lowry, J. Dhainaut, G. Beilman, 2005 .

Transforming growth factor-&bgr;: A mediator of cell regulation in acute respiratory distress syndrome

J. Chiche, J. Dhainaut, J. Charpentier, 2003, Critical care medicine.

The Splanchnic Circulation

M. Pinsky, J. Dhainaut, A. Artigas, 1995, Update in Intensive Care and Emergency Medicine.

Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis

J. Dhainaut, E. Abraham, Mark D. Williams, 2008, Critical care.

Bedside evaluation of right ventricular performance using a rapid computerized thermodilution method.

G. Iotti, A. Armaganidis, J. Dhainaut, 1987, Critical care medicine.

The Place of Extracorporeal CO2 Removal in the Treatment of ARDS

J. Dhainaut, F. Brunet, J. Dall'ava-Santucci, 1992 .

Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis

J. Dhainaut, J. Mira, A. Cariou, 2002, Critical care medicine.

Extracorporeal circulation for respiratory support in adults.

J. Dhainaut, F. Brunet, 1993, Respiratory medicine.

Hemodynamic profile in severe ARDS: results of the European Collaborative ARDS Study

J. Carlet, J. Dhainaut, A. Artigas, 1998, Intensive Care Medicine.

Pharmacokinetic‐pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis

J. Helterbrand, J. Dhainaut, M. Seger, 2002, Clinical pharmacology and therapeutics.

Decreased paradoxic pulse from increased venous return in severe asthma.

J. Dhainaut, G. Bleichner, P. Squara, 1990, Chest.

Subjective psychological status of severely ill patients discharged from mechanical ventilation.

F. Bellivier, J. Dhainaut, J. Mira, 1995, Clinical intensive care : international journal of critical & coronary care medicine.

Validity and Clinical Applications of Fast Response Thermistor for Right Ventricular Ejection Fraction Monitoring

J. Dhainaut, F. Brunet, J. Lanore, 1991 .

Sympathetic nervous system activation in postextrasystolic potentiation: role of catecholamine release in enhancement of ventricular function.

J. Dhainaut, F. Lhoste, H. Geschwind, 1984, Journal of the American College of Cardiology.

Individual Free Fatty Acids and Lactate Uptake in the Human Heart during Severe Sepsis

J. Dhainaut, F. Tallet, D. Raichvarg, 1988, Annals of clinical biochemistry.

Right ventricular function

J. Dhainaut, P. Squara, 1992 .

The Obscure Right Ventricle — A Historical Review

J. Dhainaut, J. Dall'ava-Santucci, E. Ghannad, 1988 .

Evaluation of Right Ventricular Function by Thermodilution Techniques

J. Dhainaut, F. Brunet, D. Villemant, 1987 .

Monitoring of Right Ventricular Performance in the ICU

J. Dhainaut, F. Brunet, D. Villemant, 1987 .

Measurement of Right Ventricular Ejection Fraction by Thermodilution

J. Dhainaut, F. Brunet, J. Monsallier, 1985 .

Absence of nitric oxide in airways of ventilated patients

J. Dhainaut, L. Fierobe, F. Brunet, 1994, The Lancet.

Manipulation of the Immunoinflammatory Cascade in Sepsis: Facts and Perspectives

J. Dhainaut, B. Schremmer, I. Hamy, 1990 .

Symposium: Chirurgie Cardiaque Et Agents InotropesIntroduction

J. Dhainaut, 1988 .

New Inotropic Agents in the ICU

J. Dhainaut, 1988 .

Right ventricular function in human sepsis: a thermodilution study.

M. Pinsky, J. Dhainaut, F. Brunet, 1997, Chest.

Hepatic Acute-Phase Response

J. Dhainaut, A. Mignon, D. Thebert, 1995 .

Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome.

J. Chiche, J. Dhainaut, J. Charpentier, 2003, Critical care medicine.

Passive partitioning of respiratory volumes and time constants in ventilated patients.

A. Armaganidis, J. Dhainaut, F. Brunet, 1992, The European respiratory journal.

Platelet-Activating Factor: Pathophysiological Changes and Therapeutic Implications in Sepsis

J. Dhainaut, J. Mira, L. Fierobe, 1994 .

The Pathophysiologic Foundations of Critical Care

M. Pinsky, J. Dhainaut, 2019, Critical Care Nephrology.

Role of clinical evaluation committees in sepsis trials: from 'valid cohort' assessment to subgroup analysis

J. Dhainaut, 2009, Critical care.

[Energize the university hospital].

M. Humbert, J. Dhainaut, S. Uzan, 2012, Presse medicale.

Platelet Activating Factor: Rationale for the Use of PAF-Antagonists in Sepsis

J. Dhainaut, J. Mira, F. Brunet, 1992 .

CARING FOR THE CRITICALLY ILL PATIENT Association of TNF2, a TNF-a Promoter Polymorphism, With Septic Shock Susceptibility and Mortality

J. Dhainaut, C. Delclaux, J. Mira, 1999 .

Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome.

J. Dhainaut, J. Mira, L. Fierobe, 1995, American journal of respiratory and critical care medicine.

Introduction — Hemodynamic Monitoring: A Cost/Benefit Analysis

J. Dhainaut, D. Payen, 1991 .

Hémofiltration et choc septique : impact hémodynamiqueHemofiltration and septic shock: influence on haemodynamics

J. Dhainaut, A. Cariou, C. Vinsonneau, 2003 .

Strategy in Bedside Hemodynamic Monitoring

J. Dhainaut, D. Payen, 1991, Update in Intensive Care and Emergency Medicine.

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group.

J. Dhainaut, M. Wolff, J. Mira, 1994, Critical care medicine.

Iatrogenic Complications in Adult Intensive Care Units: A Prospective Two-Center Study

Thomas T. Joseph, S. Chevret, J. Dhainaut, 1994 .

Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock

P. Barie, I. Douglas, J. Marshall, 2008, Intensive Care Medicine.

Hepatic response to sepsis: Interaction between coagulation and inflammatory processes

J. Dhainaut, C. Vinsonneau, A. Mignon, 2001, Critical care medicine.

Lack of efficacy of inhaled nitric oxide in ARDS

J. Dhainaut, J. Mira, L. Fierobe, 1994, Intensive Care Medicine.

Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure*

K. Reinhart, J. Dhainaut, A. Shorr, 2005, Critical care medicine.

Coronary Circulation in Sepsis

J. Dhainaut, J. Chiche, N. Marin, 2002 .

[Surgical treatment of acute dissection of the ascending aorta].

J. Dhainaut, I. Gandjbakhch, B. Goudot, 1977, Archives des maladies du coeur et des vaisseaux.

Only activated protein C treatment and not protein C has demonstrated an improvement in survival in severe sepsis.

H. Ehrlich, J. Dhainaut, H. Schwarz, 2004, Critical care medicine.

Computer-assisted prescription improves the delay of morphine infusion after nurse triage in patients admitted in the emergency department with intense pain: a randomized trial

J. Dhainaut, Y. Claessens, C. Ginsburg, 2006 .

Right ventricular performance in patients with acute respiratory failure

J. Dhainaut, F. Brunet, J. Devaux, 2004, Intensive Care Medicine.

Role of tricuspid regurgitation and left ventricular damage in the treatment of right ventricular infarction-induced low cardiac output syndrome.

J. Dhainaut, F. Brunet, P. Squara, 1990, The American journal of cardiology.

Right ventricular dysfunction in patients with septic shock

J. Dhainaut, F. Brunet, J. Monsallier, 2004, Intensive Care Medicine.

The PIRO Concept: R is for response

M. Levy, J. Marshall, K. Reinhart, 2003, Critical Care.

Re-establishing organ function in severe sepsis: targeting the microcirculation

J. Dhainaut, 2005, Critical Care.

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

S. Kaveri, S. Lacroix-Desmazes, M. Kazatchkine, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Unblinding plan of PROWESS-SHOCK trial

P. Barie, I. Douglas, J. Marshall, 2011, Intensive Care Medicine.

Blood Coagulation, Fibrinolysis and Cellular Haemostasis

H. Riess, J. Dhainaut, J. Lorente, 2022 .

Effects of aprotinin on hemorrhagic complications in ARDS patients during prolonged extracorporeal CO2 removal

J. Dhainaut, J. Mira, F. Brunet, 2005, Intensive Care Medicine.

Would Patients with More Subtle Signs of Coagulopathy Have Benefited from Treatment with Activated Protein C

J. Dhainaut, D. Nelson, W. Macias, 2005 .

Hemofiltration and left ventricular function in sepsis: mechanisms and clinical implications.

J. Dhainaut, C. Vinsonneau, D. Journois, 1999, Critical care medicine.

Activated protein C versus protein C in severe sepsis

J. Dhainaut, S. Yan, S. Yan, 2001, Critical care medicine.

Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis.

J. Dhainaut, A. Cariou, F. Brunet, 1998, American journal of respiratory and critical care medicine.

Extracorporeal carbon dioxide removal and low-frequency positive-pressure ventilation. Improvement in arterial oxygenation with reduction of risk of pulmonary barotrauma in patients with adult respiratory distress syndrome.

J. Dhainaut, J. Vaxelaire, J. Mira, 1993, Chest.

Myocardial Dysfunction in Sepsis

J. Dhainaut, A. Cariou, I. Laurent, 2001 .

Symptoms of anxiety and depression in family members of intensive care unit patients: Ethical hypothesis regarding decision-making capacity

J. le Gall, S. Chevret, F. Lemaire, 2001, Critical care medicine.

Expert Panel: The use of the pulmonary artery catheter

J. Vincent, P. Suter, L. Thijs, 2005, Intensive Care Medicine.

Statistical analysis plan of PROWESS SHOCK study

P. Barie, I. Douglas, J. Marshall, 2010, Intensive Care Medicine.

Diagnosis and treatment of severe sepsis

J. Dhainaut, Y. Claessens, Jean-François Dhainaut, 2007, Critical care.

Modelling of passive expiration in patients with adult respiratory distress syndrome.

J. Dhainaut, F. Brunet, A. Lockhart, 1993, The European respiratory journal.

The efficacy and safety of recombinant human activated protein C for the treatment of patients with severe sepsis (vol 28, pg 48, 2000)

Gary Garber, Jay Steingrub, Pierre-François Laterre, 2001 .

Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway.

J. Dhainaut, A. Cariou, C. Adrie, 2005, Journal of the American College of Cardiology.

Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with l-carnitine

J. Dhainaut, É. Azoulay, A. Cariou, 2003, Critical care medicine.

L-Carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues.

J. Dhainaut, A. Cariou, Y. Claessens, 2000, AIDS.

Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study.

J. Dhainaut, C. Delclaux, J. Mira, 1999, JAMA.

Drotrecogin alfa (activated) in adults with septic shock.

Andrew Rhodes, Didier Payen, Jyrki Tenhunen, 2012, The New England journal of medicine.

Introduction: rationale for using drotrecogin alfa (activated) in patients with severe sepsis.

J. Dhainaut, 2002, American journal of surgery.

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

Alain Cariou, James A Russell, J. Dhainaut, 2004, Critical care.

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis

J. Helterbrand, G. Bernard, J. Vincent, 2003, Critical care medicine.

Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial

R. F. Johnston, Robert W. Taylor, Steven C. Johnson, 1994 .

Adjunctive therapies in sepsis: An evidence-based review

J. Dhainaut, C. Vinsonneau, A. Cariou, 2004, Critical care medicine.

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

S. Opal, R. Greenman, C. Fisher, 1994, JAMA.

Efficacy and safety of recombinant human activated protein C for severe sepsis

J. Helterbrand, J. Barkun, G. Bernard, 2003 .

Normal lipase serum level in acute pancreatitis: a case report

J. Dhainaut, P. Sogni, F. Perruche, 2006, Emergency Medicine Journal.

Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial

J. Bakker, G. Bernard, J. Vincent, 2003, Intensive Care Medicine.

Coronary Hemodynamics and Myocardial Metabolism in Septic Shock

J. Dhainaut, M. Huyghebaert, 1987 .

Myocardial Metabolism in Septic Shock

J. Dhainaut, 1986 .

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.

S. Opal, J. Vincent, S. Lowry, 1997, Critical care medicine.

Noninvasive cardiac output monitoring by aortic blood flow determination: evaluation of the Sometec Dynemo-3000 system.

J. Dhainaut, A. Cariou, Y. Claessens, 1998, Critical care medicine.

Oxygen Supply Dependency in Septic Shock

A. Armaganidis, J. Dhainaut, G. Annat, 1991 .

Continuous cardiac output and mixed venous oxygen saturation monitoring.

J. Dhainaut, A. Cariou, M. Monchi, 1998, Journal of critical care.

Oxygen consumption during septic shock. Effects of inotropic drugs.

J. Dhainaut, F. Brunet, B. Schlemmer, 1984, Archives internationales de physiologie et de biochimie.

Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome

G. Bernard, J. Dhainaut, A. Shorr, 2006, Critical care.

Anticoagulant therapy in acute lung injury

J. Dhainaut, P. Laterre, X. Wittebole, 2003, Critical care medicine.

Introduction to the Third Margaux Conference on Critical Illness: The Endothelium—An Underrecognized Organ in Critical Illness?

S. Opal, J. Dhainaut, E. Abraham, 2002 .

Adult overwhelming meningococcal purpura. A study of 35 cases, 1977-1989.

P. Loirat, J. Dhainaut, B. Régnier, 1991, Archives of internal medicine.

Erythropoiesis abnormalities contribute to early-onset anemia in patients with septic shock.

J. Chiche, J. Dhainaut, N. Casadevall, 2006, American journal of respiratory and critical care medicine.

Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a “Sepsis-Like” Syndrome

J. Cavaillon, J. Dhainaut, C. Vinsonneau, 2002, Circulation.

Perspectives in Anti-Inflammatory Therapies in Sepsis

J. Dhainaut, A. Cariou, N. Marin, 2001 .

The era of genomics: Impact on sepsis clinical trial design

J. Chiche, J. Dhainaut, J. Mira, 2002, Critical care medicine.

Should mechanical ventilation be optimized to blood gases, lung mechanics, or thoracic CT scan?

A. Armaganidis, J. Dhainaut, J. Mira, 1995, American journal of respiratory and critical care medicine.

Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia.

J. Dhainaut, B. Kerlin, B. Isermann, 2003, Blood.

Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*

G. Bernard, J. Vincent, C. Putensen, 2005, Critical care medicine.

Protein C/activated protein C pathway: Overview of clinical trial results in severe sepsis

J. Dhainaut, Y. Claessens, S. Yan, 2004, Critical care medicine.

Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group.

M. Schaller, J. Dhainaut, M. Wolff, 1998, Critical care medicine.

Right Ventricular Function in ALI and ARDS

J. Dhainaut, F. Brunet, A. Dinh-Xuan, 1998 .

Reproducibility of thermodilution cardiac output determination in critically ill patients: Comparison between bolus and continuous method

Rémi Thomas, J. Dhainaut, Y. Tulzo, 1996, Journal of Clinical Monitoring.

One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis.

P. Burgel, J. Coste, J. Dhainaut, 2005, American journal of respiratory and critical care medicine.

Is intensive care justified for patients with haematological malignancies?

A. Armaganidis, J. Dhainaut, J. Vaxelaire, 2005, Intensive Care Medicine.

Combined procoagulant and innate immune responses to infection: toward more potent drugs in septic patients.

J. Dhainaut, B. Vallet, 2001, Critical care medicine.

Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial

J. Chiche, J. Dhainaut, P. Landais, 2006, The Lancet.

High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study.

J. Chiche, J. Dhainaut, C. Vinsonneau, 2005, Journal of the American College of Cardiology.

Coronary Circulation and Myocardial Ischemia

Michael R. Pinsky, M. Pinsky, J. Dhainaut, 2002, Update in Intensive Care Medicine.

Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest.

J. Chiche, J. Dhainaut, A. Cariou, 2002, Journal of the American College of Cardiology.

Immediate coronary angiography in survivors of out-of-hospital cardiac arrest.

J. Dhainaut, C. Spaulding, P. Carli, 1997, The New England journal of medicine.

The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results*

R. Schein, J. Dhainaut, D. Maki, 2003, Critical care medicine.

Inhaled nitric oxide for right ventricular dysfunction in chronic obstructive pulmonary disease patients: fall or rise of an idea?

J. Dhainaut, J. Chiche, 1999, Critical care medicine.

Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated).

G. Bernard, J. Dhainaut, S. Opal, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Severity scores for control studies in severe sepsis

J. Dhainaut, 1994 .

Is myocardial adrenergic responsiveness depressed in human septic shock?

J. Chiche, M. Pinsky, J. Dhainaut, 2008, Intensive Care Medicine.

Exhaled and nasal nitric oxide as a marker of pneumonia in ventilated patients.

M. Pinsky, J. Dhainaut, J. Dall'ava-Santucci, 2001, American journal of respiratory and critical care medicine.

Is the pulmonary artery catheter misused? A European view.

J. Vincent, P. Suter, J. Dhainaut, 1998, Critical care medicine.

Value of elementary, combined, and modeled hemodynamic variables.

J. Dhainaut, G. Bleichner, P. Squara, 1994, Journal of critical care.

Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis

J. Chiche, J. Dhainaut, S. Grabar, 2004, Critical care medicine.

Sources of variability on the estimate of treatment effect in the PROWESS trial: Implications for the design and conduct of future studies in severe sepsis*

G. Bernard, J. Vincent, J. Dhainaut, 2004, Critical care medicine.

Platelet‐activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double‐blind, placebo‐controlled, multicenter clinical trial

J. Dhainaut, M. Wolff, J. Mira, 1994 .

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study*

R. Wunderink, J. Dhainaut, D. Maki, 2005, Critical care medicine.

Extracorporeal carbon dioxide removal technique improves oxygenation without causing overinflation.

J. Dhainaut, J. Mira, L. Fierobe, 1994, American journal of respiratory and critical care medicine.

Erratum to: Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock

P. Barie, I. Douglas, J. Marshall, 2010, Intensive Care Medicine.

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

M. Levy, J. Marshall, J. Vincent, 2008 .

Underlying disorders and their impact on the host response to infection.

J. Dhainaut, Y. Claessens, D. Nelson, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pulmonary fat embolism after prostaglandin infusion in sickle cell disease with fatal outcome despite exchange blood transfusion

J. Dhainaut, D. Bachir, J. Dhainaut, 1993, American journal of hematology.

Influence of overweight on ICU mortality: a prospective study.

J. Chiche, J. Dhainaut, J. Mira, 2004, Chest.

Influence of Overweight on ICU Mortality *

J. Chiche, J. Dhainaut, J. Mira, 2004 .

studi clinici in critical care

J. Chiche, J. Dhainaut, J. Mira, 2004 .

Appropriateness of diagnosis and orientation of 996 consecutive patients admitted in an emergency department with flow-based organization

J. Dhainaut, Y. Claessens, F. Brunet, 2009, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

How emergency departments might alert for prehospital heat-related excess mortality?

J. Jais, J. Dhainaut, P. Landais, 2006, Critical care.

Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial *

G. Clermont, D. Angus, J. Dhainaut, 2004, Critical care medicine.

Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation 1

V. Pettilä, J. Dhainaut, M. Levi, 2004, Journal of thrombosis and haemostasis : JTH.

Platelet-activating factor antagonists as therapeutic strategy in sepsis.

J. Dhainaut, J. Mira, F. Brunet, 1994, Progress in clinical and biological research.

A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome

J. Vincent, P. Suter, J. Dhainaut, 2001, Intensive Care Medicine.

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial*

S. Opal, S. Lowry, W. McGee, 2004, Critical care medicine.

The use, and misuse, of exogenous endothelial-derived vasodilators in acute respiratory failure

J. Dhainaut, F. Brunet, A. Dinh-Xuan, 1997, Intensive Care Medicine.

Health network to improve elderly patients' flow in emergency department

J. Dhainaut, F. Bloch, K. Takun, 2006, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Inhaled Nitric Oxide: The Light and Shadow of a Therapeutic Breakthrough

J. Dhainaut, F. Brunet, A. Dinh-Xuan, 1995 .

Causes of error of respiratory pressure-volume curves in paralyzed subjects.

A. Armaganidis, J. Dhainaut, F. Brunet, 1988, Journal of applied physiology.

The splanchnic circulation : no longer a silent partner

M. Pinsky, J. Dhainaut, A. Artigas, 2011 .

Lack of oxygen supply dependency in patients with severe sepsis. A study of oxygen delivery increased by military antishock trouser and dobutamine.

J. Coste, J. Dhainaut, J. Mira, 1994, Chest.

A single-compartment model cannot describe passive expiration in intubated, paralysed humans.

A. Armaganidis, J. Dhainaut, F. Brunet, 1991, The European respiratory journal.

Respiratory Inductive Plethysmography for Assessing Risk of Pulmonary Barotrauma

J. Dhainaut, F. Brunet, J. Dall'ava-Santucci, 1992 .

Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock.

J. Dhainaut, A. Cariou, F. Brunet, 1999, American journal of respiratory and critical care medicine.

Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock

M. Antonelli, J. Dhainaut, J. Reignier, 2009, Intensive Care Medicine.

Early goal-directed therapy in the treatment of severe sepsis and septic shock

J. Helterbrand, P. Singer, T. Evans, 2002 .

Unprecedented heat-related deaths during the 2003 heat wave in Paris: consequences on emergency departments

J. Dhainaut, Y. Claessens, Christine Ginsburg, 2003, Critical care.

French intensivists do not apply American recommendations regarding decisions to forgo life-sustaining therapy

S. Chevret, F. Lemaire, J. Dhainaut, 2001, Critical care medicine.

Using connected objects in clinical research.

Laure Huot, Jean-François Dhainaut, Valérie Bouchara Pomar, 2018, Therapie.

Mechanical effects of PEEP in patients with adult respiratory distress syndrome.

A Armaganidis, D Morisseau, A. Armaganidis, 1990, Journal of applied physiology.

Myocardial depressant substances as mediators of early cardiac dysfunction in septic shock

J. Dhainaut, 1989 .

Human polymorphonuclear leukocyte metabolism and lipoperoxidation during adult respiratory distress syndrome treated by extracorporeal carbon dioxide removal

J. Dhainaut, J. Vaxelaire, F. Brunet, 1994 .

Risk factors for post-ICU red blood cell transfusion: a prospective study

J. Chiche, J. Dhainaut, J. Mira, 2006, Critical care.

Right Ventricular Performance During Mechanical Ventilation in ARDS

J. Dhainaut, F. Brunet, 1988 .

The pulmonary circulation : moving from passive to active control

M. Pinsky, J. Dhainaut, A. Artigas, 1996 .

The Treatment of Sepsis

S. Opal, M. Haller, J. Briegel, 1910, Intensive Care Medicine.

SAFETY PROFILE OF DROTRECOGIN ALFA (ACTIVATED) IN SEVERE SEPSIS PATIENTS FROM THE INDEPTH INTEGRATED DATABASE: 615

J. Dhainaut, P. Laterre, D. Nelson, 2004 .

Clinical evaluation of the Abbott Qvue-OptiQ continuous cardiac output system in critically ill medical patients.

J. Dhainaut, A. Cariou, F. Brunet, 1998, Journal of critical care.

Cost-effectiveness of activated protein C in real-life clinical practice

D. Annane, J. Dhainaut, B. Guidet, 2007, Critical care.

Computer Assistance for Hemodynamic Evaluation

M. Lamy, A. Armaganidis, J. Dhainaut, 1989 .

Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?

O. Blin, P. Marquet, J. Dhainaut, 2019, Therapie.

NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance.

J. Cavaillon, M. Pinsky, J. Dhainaut, 2000, American journal of respiratory and critical care medicine.

Mechanical Ventilation should be Individually Optimized in Patients with ARDS

J. Dhainaut, F. Brunet, J. Dall'ava-Santucci, 1995 .

Do ED staffs have a role to play in the prevention of repeat falls in elderly patients?

J. Lundy, J. Coste, J. Dhainaut, 2009, The American journal of emergency medicine.

Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis.

M. Adib-Conquy, J. Cavaillon, M. Pinsky, 2001, American journal of respiratory and critical care medicine.

Outcome of patients with systemic rheumatic disease admitted to medical intensive care units.

C. Chastang, J. Dhainaut, F. Brunet, 1992, Annals of the rheumatic diseases.

LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.

J. Dhainaut, P. Briand, V. Joulin, 1999, American journal of respiratory and critical care medicine.

Transforming growth factor- : A mediator of cell regulation in acute respiratory distress syndrome

J. Chiche, J. Dhainaut, J. Charpentier, 2003 .

Platelet‐activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double‐blind, placebo‐controlled, multicenter clinical trial

J. Dhainaut, M. Wolff, J. Mira, 1994, Critical care medicine.

International integrated database for the evaluation of severe sepsis (INDEPTH): clinical evaluation committee report on the safety of drotrecogin alfa (activated) therapy*

J. Dhainaut, 2008, Current medical research and opinion.

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

J. Dhainaut, A. Cariou, P. Laterre, 2004, Critical care.

Reduction of ventilator settings allowed by intravenous oxygenator (IVOX) in ARDS patients

J. Dhainaut, J. Mira, L. Fierobe, 2006, Intensive Care Medicine.

Influence of overweight on ICU mortality: a prospective study.

J. Chiche, J. Dhainaut, J. Mira, 2004, Chest.